scispace - formally typeset
S

Silvia Ravera

Researcher at University of Genoa

Publications -  217
Citations -  4435

Silvia Ravera is an academic researcher from University of Genoa. The author has contributed to research in topics: Mitochondrion & ATP synthase. The author has an hindex of 33, co-authored 190 publications receiving 3444 citations. Previous affiliations of Silvia Ravera include Istituto Giannina Gaslini & University of Zurich.

Papers
More filters
Journal ArticleDOI

The Arabidopsis vacuolar malate channel is a member of the ALMT family

TL;DR: Deletion mutants for AtALMT9 exhibit only slightly reduced malate content in mesophyll protoplasts and no visible phenotype, indicating that AttDT and the residual malate channel activity are sufficient to sustain the transport activity necessary to regulate the cytosolic malate homeostasis.
Journal ArticleDOI

The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications

TL;DR: This review focuses on the most recent findings on I- homeostasis and I- transport deficiency-causing NIS mutations, as well as current knowledge of the structure/function properties of NIS and NIS regulatory mechanisms.
Journal ArticleDOI

The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi

TL;DR: It is shown that a member of the SLC20 gene family (PiT-2) is localized to the brush-border membrane (BBM) of the PT epithelia and that its abundance, confirmed by Western blot and immunohistochemistry of rat kidney slices, is regulated by dietary P(i).
Journal ArticleDOI

Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models

TL;DR: Findings indicate that the glucose and amino acid deficiency conditions imposed by STS promote an anti-Warburg effect characterized by increased oxygen consumption but failure to generate ATP, resulting in oxidative damage and apoptosis.
Journal ArticleDOI

Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer

TL;DR: It is demonstrated that metformin directly inhibits the enzymatic function of hexokinase (HK) I and II in a cell line of triple-negative breast cancer (MDA-MB-231), and results strongly suggest that HK inhibition contributes to met formin therapeutic and preventive potential in breast cancer.